InvestorsHub Logo
Post# of 252501
Next 10

BTH

Followers 16
Posts 4145
Boards Moderated 1
Alias Born 06/11/2010

BTH

Re: bladerunner1717 post# 149844

Tuesday, 10/02/2012 2:41:48 PM

Tuesday, October 02, 2012 2:41:48 PM

Post# of 252501

There are people on this board a lot smarter that you or I who were long ARQL. So was Ohad Hammer



It's called gamling. Like what most of biotech investing is; until you have an almost sure thing, like Ponatinib. Otherwise, it's trying to find some sort of solace in identifying risk/reward. I do have position in ARQL - because it still has HCC and other drugs behind, as well as cash - however, my size was small here, because the chart smelled outright bad news, and for reasons discussed here many times about the trial design. $300M looked cheap yesterday, looks even cheaper today. But its eons away from ever getting back to a $500M market cap.



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.